Investigations of Laser-Assisted Renal Denervation for Treatment of Resistant Hypertension

被引:0
|
作者
Hwang, Junghyun [1 ,2 ]
Shin, Hwarang [2 ,3 ]
Jung, Minwoo [1 ]
Kang, Hyun Wook [1 ,2 ,3 ,4 ]
机构
[1] Pukyong Natl Univ, Coll Informat Technol & Convergence, Div Smart Healthcare, Biomed Engn, Busan, South Korea
[2] Pukyong Natl Univ, Marine Integrated Biomed Technol Ctr, Busan, South Korea
[3] Pukyong Natl Univ, Ind 4 0 Convergence B Engn, Busan, South Korea
[4] TeCure Inc, Appl R&D, Busan, South Korea
基金
新加坡国家研究基金会;
关键词
diffusing applicator; endovascular; hypertension; renal denervation; resistant hypertension; SYMPATHETIC DENERVATION; BLOOD-PRESSURE; BALLOON CATHETER; ABLATION; ULTRASOUND; STATEMENT; SENSORS; SAFETY; TRIAL;
D O I
10.1002/lsm.23823
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background and ObjectivesRenal denervation (RDN) is an emerging surgical treatment for resistant hypertension. However, the current RDN using radiofrequency can cause undesirable thermal damage to the medial and luminal layers due to direct contact between the arterial lumen and energy source. The aim of this study is to evaluate the feasibility of the new laser-assisted RDN by exploring the potential treatment conditions.MethodsFor ex vivo testing, six different treatment conditions (10 and 20 W applied for delivery of 300, 450, and 600 J) were tested on the porcine liver and renal artery (RA) by using a continuous wave 1064 nm laser wavelength. The ablated area in the liver tissue was measured to estimate the extent of the coagulated area. Histological evaluation was performed on the treated RA tissues to confirm the extent of thermal nerve damage.ResultsThe ablated depth, length, and area in the liver tissue increased with laser power and total energy. According to the histological results, 20 W groups yielded more significant damage to the RA nerves than 10 W groups at the total energy of 300 J (0.0 +/- 0.0 mm for 10 W vs. 2.9 +/- 1.0 mm for 20 W), 450 J (1.9 +/- 0.6 mm for 10 W vs. 6.8 +/- 1.5 mm for 20 W), and 600 J (2.9 +/- 0.4 mm for 10 W vs. 7.3 +/- 0.8 mm for 20 W). The treated RA exhibited insignificant medial injury in depth (medial thinning <= 25%), and no difference in the medial thinning was found among the six groups (p = 0.4).ConclusionThe current study demonstrated that the 1064 nm laser at 20 W with delivery of 450 J could effectively damage the RA nerves with no or minimal injury to the surrounding tissue. The proposed laser-assisted RDN may enhance physiological effects with insignificant complications in in vivo situations. Further in vivo studies will be conducted to validate the current findings by evaluating the extent of blood pressure reduction and norepinephrine changes after the laser-assisted RDN on a large animal model.
引用
收藏
页码:664 / 672
页数:9
相关论文
共 50 条
  • [11] Renal Denervation for Resistant Hypertension: Where Do We Stand?
    Liang, Bo
    Zhao, Yu-Xiu
    Gu, Ning
    CURRENT HYPERTENSION REPORTS, 2020, 22 (10)
  • [12] Renal Denervation for Resistant Hypertension Not Dead Yet
    Reddy, Vivek Y.
    Olin, Jeffrey W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : 1088 - 1091
  • [13] Transradial Renal Denervation for the Treatment of Resistant Hypertension
    Dong, Hui
    Jiang, Xiongjing
    Liang, Tuo
    Zou, Yubao
    Guan, Ting
    Peng, Meng
    Song, Lei
    Zhang, Huimin
    Wu, Haiying
    Xu, Bo
    Yang, Yuejin
    Gao, Runlin
    JOURNAL OF INVASIVE CARDIOLOGY, 2014, 26 (07) : 322 - 327
  • [14] Renal denervation in the treatment of resistant hypertension: Dead, alive or surviving?
    Al-Fakhouri, Ahmad
    Efeovbokhan, Nephertiti
    Nakhla, Rami
    Khouzam, Rami N.
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2016, 35 (10) : 531 - 538
  • [15] Expert consensus: Renal denervation for the treatment of arterial hypertension
    Pathak, Atul
    Girerd, Xavier
    Azizi, Michel
    Benamer, Hakim
    Halimi, Jean-Michel
    Lantelme, Pierre
    Lefevre, Thierry
    Sapoval, Marc
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2012, 105 (6-7) : 386 - 393
  • [16] Catheter-based renal denervation in the treatment of resistant hypertension
    Stouffer, G. A.
    DiBona, G. F.
    Patel, A.
    Kaul, P.
    Hinderliter, A. L.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2013, 62 : 18 - 23
  • [17] The effects of renal denervation on resistant hypertension patients: a meta-analysis
    Zhang, Xiaojuan
    Wu, Nie
    Yan, Wenjuan
    Zhou, Chunya
    Guo, Hua
    BLOOD PRESSURE MONITORING, 2016, 21 (04) : 206 - 214
  • [18] Renal denervation: a new therapeutic approach for resistant hypertension
    Cao Longxing
    Fu Qiang
    Wang Binghui
    Li Zhiliang
    CHINESE MEDICAL JOURNAL, 2014, 127 (18) : 3302 - 3308
  • [19] International Expert Consensus Statement Percutaneous Transluminal Renal Denervation for the Treatment of Resistant Hypertension
    Schlaich, Markus P.
    Schmieder, Roland E.
    Bakris, George
    Blankestijn, Peter J.
    Boehm, Michael
    Campese, Vito M.
    Francis, Darrel P.
    Grassi, Guido
    Hering, Dagmara
    Katholi, Richard
    Kjeldsen, Sverre
    Krum, Henry
    Mahfoud, Felix
    Mancia, Giuseppe
    Messerli, Franz H.
    Narkiewicz, Krzysztof
    Parati, Gianfranco
    Rocha-Singh, Krishna J.
    Ruilope, Luis M.
    Rump, Lars C.
    Sica, Domenic A.
    Sobotka, Paul A.
    Tsioufis, Costas
    Vonend, Oliver
    Weber, Michael A.
    Williams, Bryan
    Zeller, Thomas
    Esler, Murray D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (22) : 2031 - 2045
  • [20] Predictors of Renal Denervation Efficacy in the Treatment of Resistant Hypertension
    Ripp, Tatiana M.
    Mordovin, Victor F.
    Pekarskiy, Stanislav E.
    Ryabova, Tamara R.
    Zlobina, Marina V.
    Baev, Andrei E.
    Anfinogenova, Yana
    Popov, Sergey V.
    CURRENT HYPERTENSION REPORTS, 2015, 17 (12)